MicroPort CardioFlow Medtech Corp. operates as a holding company with interest in developing medical devices. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2021-02-04. The Company’s main business is engaged in the research and development and commercialization of transcatheter and surgical solutions for structural heart diseases. The Company’s pipelines include transcatheter aortic heart valve implantation (TAVI) series products, AnchorMan left atrial appendage closure (LAAC) product, transcatheter mitral valve (TMV) products, transcatheter tricuspid valve (TTV) products and procedural accessories. The firm conducts its business in the domestic and overseas markets.
Follow-Up Questions
What is the price performance of MROPF stock?
The current price of MROPF is $0, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Microport Cardioflow Medtech Corp?
Microport Cardioflow Medtech Corp belongs to Health Care industry and the sector is Health Care
What is Microport Cardioflow Medtech Corp market cap?
Microport Cardioflow Medtech Corp's current market cap is $0
Is Microport Cardioflow Medtech Corp a buy, sell, or hold?
According to wall street analysts, 9 analysts have made analyst ratings for Microport Cardioflow Medtech Corp, including 2 strong buy, 4 buy, 1 hold, 0 sell, and 2 strong sell
